8月7日早间博安生物在港交所公告于2025年8月6日公司及配售代理订立配售协议。可能根据配售事项出售的配售股份总数为48

智通财经
Aug 07
8月7日早间博安生物在港交所公告于2025年8月6日公司及配售代理订立配售协议。可能根据配售事项出售的配售股份总数为4800万股相当于于本公告日期的已发行股份总数约8.36%。配售价为每股16.42港元较股份于最后交易日在联交所所报收市价折让约8.78%。预期配售事项所得款项净额约为7.80亿港元约50%将用于研发、临床试验、注册文件及制造创新候选产品;约20%将用于已上市及即将上市产品的商业化;约30%将用于补充公司营运资金及一般企业用途。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10